The present disclosure relates to immunomodulatory fusion proteins containing an extracellular binding domain and an intracellular signaling domain wherein binding of a target can generate a modulatory signal in a host cell such as a T cell. The present disclosure also relates to uses of immune cells expressing such immunomodulatory fusion proteins to treat certain diseases such as cancer or infectious disease.